XB-ART-58353
Elife
2021 Jul 08;10. doi: 10.7554/eLife.69544.
Show Gene links
Show Anatomy links
Crosstalk between repair pathways elicits double-strand breaks in alkylated DNA and implications for the action of temozolomide.
Fuchs RP
,
Isogawa A
,
Paulo JA
,
Onizuka K
,
Takahashi T
,
Amunugama R
,
Duxin JP
,
Fujii S
.
???displayArticle.abstract???
Temozolomide (TMZ), a DNA methylating agent, is the primary chemotherapeutic drug used in glioblastoma treatment. TMZ induces mostly N-alkylation adducts (N7-methylguanine and N3-methyladenine) and some O6-methylguanine (O6mG) adducts. Current models propose that during DNA replication, thymine is incorporated across from O6mG, promoting a futile cycle of mismatch repair (MMR) that leads to DNA double-strand breaks (DSBs). To revisit the mechanism of O6mG processing, we reacted plasmid DNA with N-methyl-N-nitrosourea (MNU), a temozolomide mimic, and incubated it in Xenopus egg-derived extracts. We have shown that in this system, MMR proteins are enriched on MNU-treated DNA and we observed robust, MMR-dependent, repair synthesis. Our evidence also suggests that MMR, initiated at O6mG:C sites, is strongly stimulated in cis by repair processing of other lesions, such as N-alkylation adducts. Importantly, MNU-treated plasmids display DSBs in extracts, the frequency of which increases linearly with the square of alkylation dose. We suggest that DSBs result from two independent repair processes, one involving MMR at O6mG:C sites and the other involving base excision repair acting at a nearby N-alkylation adduct. We propose a new, replication-independent mechanism of action of TMZ, which operates in addition to the well-studied cell cycle-dependent mode of action.
???displayArticle.pubmedLink??? 34236314
???displayArticle.link??? Elife
???displayArticle.grants??? [+]
R01 GM132129 NIGMS NIH HHS , JP20H05392 Japan Society for the Promotion of Science , JP20H03186 Japan Society for the Promotion of Science , R01 GM132129 NIH HHS
Species referenced: Xenopus laevis
Genes referenced: alk exo1 mrc1 tspo
GO keywords: DNA double-strand break processing [+]
???displayArticle.disOnts??? glioblastoma
???attribute.lit??? ???displayArticles.show???
Figure 1. Pull-down of proteins that bind to alkylated versus untreated plasmid DNA. (A) Experimental workflow. Plasmid DNA (pAS04, 6.5 kb) was treated with alkylating agents under conditions leading to a similar extent of N-alkylation (â one alkaline cleavage site every 500 nt) (Figure 1âfigure supplement 1A). Immobilized plasmid DNA was incubated in Xenopus nucleoplasmic extracts (NPE) for 10 min at room temperature under mild agitation. The reaction was stopped by addition of formaldehyde (0.8% final) to cross-link the protein-DNA complexes. The beads were processed and analyzed by polyacrylamide gel electrophoresis (PAGE) or by mass spectrometry (MS) as described in 'Materials and methods'. (B) Relative abundance of proteins captured on N-methyl-N-nitrosourea (MNU)-treated versus -untreated DNA0. Proteins captured on equal amounts of MNU-treated or -untreated plasmid were analyzed by label-free MS in triplicate. For all proteins, average spectral count values in the MNU-treated plasmid sample were divided by the average spectral count values in the DNA0 sample. The resulting ratio is plotted as its log2 value along x-axis. The statistical significance of the data is estimated by the p-value in the Studentâs t-test and plotted as -log10p along y-axis. Proteins enriched on MNU versus untreated plasmid DNA appear on the right-side top corner and essentially turn out to be mismatch repair (MMR) proteins labeled in red (B). Data shown are analyzed using Xenbase database. (C) Relative abundance of proteins captured on methyl-methane sulfonate (MMS)-treated versus -untreated DNA0. Proteins captured on equal amounts of MMS-treated or -untreated plasmid were analyzed by label-free MS in triplicate. The data are analyzed and plotted as in panel (B) for MNU using Xenbase database. Proteins (labeled in green in B and C) are found enriched or excluded in both MMS versus DNA0 and MNU versus DNA0 plasmids. We suggest these proteins are recruited or excluded from binding to DNA by the abundant class of N-alkylation adducts that both MMS- and MNU-treated plasmids share in common (~27 N-alkyl adducts per plasmid). | |
Figure 2 DNA repair synthesis in alkylated and undamaged control plasmid DNA in NPE. (A) Outline of the spot assay. Plasmids were incubated in nuclear extracts supplemented with α32P-dATP; at various time points, an aliquot of the reaction mixture was spotted on DEAE paper (see 'Materials and methods'). The dot blot is shown for the sake of illustration only. (B) Plasmid DNA pBR322 (4.3 kb) samples, modified to a similar extent with -MMS, -MNU and -ENU, were incubated in nucleoplasmic extracts (NPE) supplemented with α32P-dATP at room temperature; incorporation of radioactivity was monitored as a function of time using the spot assay described above (A). Undamaged plasmid DNA0 was used as a control. At each time point, the average values and standard deviation from three independent experiments were plotted. The y-axis represents DNA repair synthesis expressed as a fraction of input plasmid replication (i.e., 10% means that the observed extent of repair synthesis is equivalent to 10% of input plasmid replication). This value was determined knowing the average concentration of dATP in the extract (50 μM) and the amount of added α32P-dATP. (C) N-methyl-N-nitrosourea (MMS)- and N-methyl-N-nitrosourea (MNU)-treated plasmids were incubated in NPE, supplemented or not, by aphidicolin (150 μM final). After 1 hr of incubation, plasmids were purified and analyzed by agarose gel electrophoresis under neutral loading conditions. The gel was imaged by fluorescence (left: ethidium bromide image) and by autoradiography (right: 32P image). The number below each lane indicates the total amount of signals per lane (expressed in arbitrary units [AU]). Aphidicolin treatment decreases incorporation into MNU-treated plasmid close to fourfold, while it affected incorporation into MMS-treated plasmid only 1.6-fold. (D) Samples as in (C). Gel loading is performed under alkaline conditions to denature DNA before entering the neutral agarose gel, allowing single-stranded nicks present in DNA to be revealed. The number below each lane indicates the amount of signals per lane (AU). | |
Figure 3 Stimulation of MMR at a single O6mG site by N-alkyl adducts in cis. (A) Covalently closed circular (ccc) plasmids (pAS200.2, 2.1 kb) containing a site-specific O6mG:C base pair (plasmid mGC) and the corresponding lesion-free control (plasmid GC) were constructed (Isogawa et al., 2020). Similarly, plasmids with a site-specific GT or a O6mG:T mismatch were constructed. All the four constructs were treated with methyl-methane sulfonate (MMS) in order to introduce random N-alkyl (7mG and 3mA) adducts, generating plasmids GC+MMS, mGC+MMS, GT+MMS, and mGT+MMS. We adjusted the MMS reaction conditions as to introduce â nine adducts per plasmid (i.e., one N-alkylation adduct every â500 nt). The resulting proportion of O-alk and N-alkyl adducts mimics the proportion in N-methyl-N-nitrosourea (MNU)-treated plasmids. The single O6mG adduct and the randomly located N-alkyl adducts are represented by a star and red dots, respectively. (B) Plasmids described above were incubated in nucleoplasmic extracts (NPE) supplemented with α32P-dATP at room temperature; incorporation of radioactivity was monitored as a function of time using the spot assay. The y-axis represents the percentage of DNA repair synthesis with respect to input DNA (i.e., 10% means that the observed extent of repair synthesis is equivalent to 10% of input plasmid replication). Overall, incorporation into GT and mGT plasmids is higher than incorporation into their GC and mGC counterparts. Incorporation attributable to repair at the O6mG:C lesion is increased close to threefold due to the presence of random N-alkyl lesions introduced by MMS treatment. The stimulatory effect of random N-alkyl lesions on GT and mGT repair is observed but is slightly less pronounced than for mGC. (C) The same plasmids were incubated for 2 hr in NPE, purified, resolved by agarose gel electrophoresis, and revealed by ethidium bromide fluorescence and 32P autoradiography. The total amount of signals per lane is indicated (arbitrary units [AU]). As expected, the amount of plasmid extracted from each incubation mix is relatively constant, as quantified below the ethidium bromide image. Increase in repair at the O6mG:C lesion due to MMS treatment (2.8-fold) is in good agreement with data in (B). | |
Figure 4 Double-strand breaks occur in MNU-treated plasmids during incubation in extracts. (A) Analysis by agarose gel electrophoresis (AGE) of alkylated plasmids (pEL97: 11.3 kb) incubated in nucleoplasmic extracts (NPE) in the presence of α32P-dATP. Plasmid pEL97 was treated with methyl-methane sulfonate (MMS), N-methyl-N-nitrosourea (MNU)+, and ENU as to introduce â one alkylation event, on average, every 500 nt. For MNU, a plasmid with twice the level of alkylation (MNU++, one lesion every 250 nt) was also produced (Figure 4âfigure supplement 1). Alkylation of these plasmids essentially not affected their migration on agarose gels (Figure 4âfigure supplement 2A). After 2 hr of incubation, the reaction was stopped and a known amount of pBR322 (10 ng) plasmid was added as an internal standard. Ethidium bromide image: in different lanes, the internal standard band, pBR (covalently closed circular [ccc]), appears to be of similar intensity (1158 +/- 95 arbitrary units [AU]), assessing reproducible DNA extraction. For the alkylated plasmids, incubation in NPE led to massive conversion from ccc to relaxed plasmids. 32P image: little incorporation of 32P-dATP is seen in DNA0 and in MMS-treated plasmids compared to MNU- and ENU-treated plasmids as shown by the relative incorporation levels normalized to one for untreated plasmid (DNA0). As expected, the MNU++ sample exhibits about twice the amount of incorporated radioactivity compared to MNU+. In both ethidium bromide and 32P images, a small amount of linear plasmid is seen mostly in the MNU++ sample. This band is also visible in the MNU+ and ENU lanes although at a weaker intensity. (B) Quadratic dose-response for double-strand break (DSB) formation. When the % of linear form (linear/(linear + oc)) is plotted as a function of the square dose of MNU (mM2) for untreated, MNU+, and MNU++ plasmids, we observed a straight line (y = 1.4173x - 0.0288; R² = 0.9999). | |
Figure 5 Simultaneous repair of two closely spaced MNU-induced lesions may lead to a DSB. Such a situation occurs when an N-alkyl lesion located within â500 nt of an O6mG lesion is processed simultaneously (âLesion Arrangement at-riskâ). Note that the mismatch repair (MMR) excision track can occur on either strand as described for noncanonical MMR (Peña-Diaz et al., 2012). Reaction of N-methyl-N-nitrosourea (MNU) with double-stranded DNA induces N-alkylation adducts, mostly 7mG and 3mA shown as * and O-alkylation adducts (O6mG), at a ratio of 10:1 approximately. Step 1: a base excision repair (BER) event is initiated at an N-alkyl adduct, creating a nick. Step 2: concomitantly, an MMR event takes place, in the opposite strand, at a nearby O6mG:C site. Step 3: the MMR machinery extends the nick into a several hundred nt-long gap by means of Exo1 action. Step 4: the two independently initiated repair events lead to a double-strand break (DSB), if the MMR gap reaches the BER-initiated nick before resealing. |
References [+] :
Aas,
Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA.
2003, Pubmed
Aas, Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. 2003, Pubmed
Baranovskiy, Structural basis for inhibition of DNA replication by aphidicolin. 2014, Pubmed
Beranek, Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. 1990, Pubmed
Bhanot, The in vivo mutagenic frequency and specificity of O6-methylguanine in phi X174 replicative form DNA. 1986, Pubmed
Bobola, Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression. 2010, Pubmed
Bregenhorn, Non-canonical uracil processing in DNA gives rise to double-strand breaks and deletions: relevance to class switch recombination. 2016, Pubmed
Cejka, Interplay of DNA repair pathways controls methylation damage toxicity in Saccharomyces cerevisiae. 2008, Pubmed
Chakravarti, Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase. 1991, Pubmed
Day, Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. 1980, Pubmed
Demple, Repair of alkylated DNA in Escherichia coli. Physical properties of O6-methylguanine-DNA methyltransferase. 1982, Pubmed
Duckett, hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage. 1999, Pubmed
Duncan, Reversal of DNA alkylation damage by two human dioxygenases. 2002, Pubmed
Elias, Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. 2007, Pubmed
Elias, Target-decoy search strategy for mass spectrometry-based proteomics. 2010, Pubmed
Ensminger, DNA breaks and chromosomal aberrations arise when replication meets base excision repair. 2014, Pubmed
Falnes, AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. 2002, Pubmed
Goldmacher, Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N'-nitro-N-nitrosoguanidine. 1986, Pubmed
Graham, Two-Stage Synapsis of DNA Ends during Non-homologous End Joining. 2016, Pubmed
Gupta, The mismatch repair-dependent DNA damage response: Mechanisms and implications. 2019, Pubmed
Huttlin, Architecture of the human interactome defines protein communities and disease networks. 2017, Pubmed
Isogawa, Versatile and efficient chromatin pull-down methodology based on DNA triple helix formation. 2018, Pubmed
Isogawa, Chromatin Pull-Down Methodology Based on DNA Triple Helix Formation. 2020, Pubmed
Jiricny, The multifaceted mismatch-repair system. 2006, Pubmed
Kaina, MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. 2007, Pubmed
Kaina, Corrigendum to "DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas" [DNA Repair 78 (2019) 128-141]. 2019, Pubmed
Karran, O6-methylguanine residues elicit DNA repair synthesis by human cell extracts. 1993, Pubmed
Karran, Mechanisms of tolerance to DNA damaging therapeutic drugs. 2001, Pubmed
Karran, DNA damage tolerance, mismatch repair and genome instability. 1994, Pubmed
Karran, Mismatch correction at O6-methylguanine residues in E. coli DNA. 1982, Pubmed
Kat, An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. 1993, Pubmed
Kato, Sensing and Processing of DNA Interstrand Crosslinks by the Mismatch Repair Pathway. 2017, Pubmed , Xenbase
Kawasoe, MutSα maintains the mismatch repair capability by inhibiting PCNA unloading. 2016, Pubmed , Xenbase
Lebofsky, DNA replication in nucleus-free Xenopus egg extracts. 2009, Pubmed , Xenbase
Lindahl, New class of enzymes acting on damaged DNA. , Pubmed
Liu, Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway. 2010, Pubmed
Loechler, In vivo mutagenesis by O6-methylguanine built into a unique site in a viral genome. 1984, Pubmed
Loechler, A violation of the Swain-Scott principle, and not SN1 versus SN2 reaction mechanisms, explains why carcinogenic alkylating agents can form different proportions of adducts at oxygen versus nitrogen in DNA. 1994, Pubmed
Maxam, A new method for sequencing DNA. 1977, Pubmed
Mazon, Alkyltransferase-like protein (eATL) prevents mismatch repair-mediated toxicity induced by O6-alkylguanine adducts in Escherichia coli. 2010, Pubmed
Meira, Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice. 2009, Pubmed
Moody, The medicinal chemistry of imidazotetrazine prodrugs. 2014, Pubmed
Nagatsugi, Site-specific mutagenesis by triple helix-forming oligonucleotides containing a reactive nucleoside analog. 2003, Pubmed
Noonan, O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation. 2012, Pubmed
Nowosielska, DNA mismatch repair-induced double-strand breaks. 2008, Pubmed
Ochs, Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. 2000, Pubmed
Olivera Harris, Mismatch repair-dependent metabolism of O6-methylguanine-containing DNA in Xenopus laevis egg extracts. 2015, Pubmed , Xenbase
Olsson, Repair of alkylated DNA in Escherichia coli. Methyl group transfer from O6-methylguanine to a protein cysteine residue. 1980, Pubmed
Ortega, Mispair-bound human MutS-MutL complex triggers DNA incisions and activates mismatch repair. 2021, Pubmed
Peña-Diaz, Noncanonical mismatch repair as a source of genomic instability in human cells. 2012, Pubmed
Plant, A novel mechanism for the inhibition of DNA synthesis following methylation: the effect of N-methyl-N-nitrosourea on HeLa cells. 1971, Pubmed
Pluciennik, PCNA function in the activation and strand direction of MutLα endonuclease in mismatch repair. 2010, Pubmed
Pluciennik, Extrahelical (CAG)/(CTG) triplet repeat elements support proliferating cell nuclear antigen loading and MutLα endonuclease activation. 2013, Pubmed
Quiros, Processing of O6-methylguanine into DNA double-strand breaks requires two rounds of replication whereas apoptosis is also induced in subsequent cell cycles. 2010, Pubmed
Repmann, Influence of oxidized purine processing on strand directionality of mismatch repair. 2015, Pubmed , Xenbase
Sattler, Long-patch DNA repair synthesis during base excision repair in mammalian cells. 2003, Pubmed
Schanz, Interference of mismatch and base excision repair during the processing of adjacent U/G mispairs may play a key role in somatic hypermutation. 2009, Pubmed
Simonelli, Crosstalk between mismatch repair and base excision repair in human gastric cancer. 2017, Pubmed
Strobel, Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. 2019, Pubmed
Tang, N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. 2011, Pubmed
Tano, Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine. 1990, Pubmed
Trewick, Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. 2002, Pubmed
Trivedi, The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death. 2005, Pubmed
Walter, Regulated chromosomal DNA replication in the absence of a nucleus. 1998, Pubmed , Xenbase
Wühr, Deep proteomics of the Xenopus laevis egg using an mRNA-derived reference database. 2014, Pubmed , Xenbase
Yarosh, Repair of O6-methylguanine in DNA by demethylation is lacking in Mer- human tumor cell strains. 1983, Pubmed
York, Mismatch repair-dependent iterative excision at irreparable O6-methylguanine lesions in human nuclear extracts. 2006, Pubmed
Yoshioka, ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. 2006, Pubmed
Zlatanou, The hMsh2-hMsh6 complex acts in concert with monoubiquitinated PCNA and Pol η in response to oxidative DNA damage in human cells. 2011, Pubmed